Trulieve Cannabis Corp. Securities Litigation

If you purchased a significant amount of shares of TRULIEVE CANNABIS CORP (US TRADING VENUE: TCNNF), you have certain options. Investors should contact us.

 

Lawsuit Overview

Defendant:TRULIEVE CANNABIS CORP
Date Filed:December 30th, 2019
Class Start Date:September 25th, 2018
Class End Date:December 17th, 2019

According to the Complaint, Trulieve, together with its subsidiaries, purports to operate as a medical marijuana company. The Company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as directly to patients through home delivery.

The Complaint alleges that Defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Trulieve overstated its mark-up on its biological assets; (2) therefore, Trulieve's reported gross profit was inflated; (3) Trulieve engaged in an undisclosed related party real estate sale with Defendant Rivers' husband; and (4) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Sign up for free to create a personalized portfolio with tracking and e-mail alerts for TRULIEVE CANNABIS CORP

 
First Identified Complaint

David McNear, et al. v. Trulieve Cannabis Corp., et al.

Date Filed:December 30th, 2019
Class Period Start:September 25th, 2018
Class Period End:December 17th, 2019
First Identified Complaint Filings
#Document TitleFiling Date